Login / Signup

CD5 positive B-ALL, a uniquely aggressive subcategory of B-ALL? A case report and brief review of the literature.

Elizabeth M StaleyAlexander Z FeldmanRichard G KoenigBenjamin Hill
Published in: Pediatric blood & cancer (2018)
CD5 antigen expression in B-cell acute lymphoblastic leukemia (B-ALL) is exceptionally rare. There are six detailed case reports in the literature, with only 16 cases described. Case series analyzing the frequency of aberrant B-ALL immunophenotypes suggest that this variant may occur in as little as 2-4.5% of all B-ALL cases, with one series having no CD5+ positive cases. Herein we report a case of CD5+ B-ALL in a 15-year-old female, and review the previously reported cases. As limited information is available, more data from prospective clinical trials are required to determine whether CD5 positivity portends a poorer prognosis.
Keyphrases
  • acute lymphoblastic leukemia
  • clinical trial
  • nk cells
  • systematic review
  • poor prognosis
  • big data
  • long non coding rna